Funder: Crohn's and Colitis Foundation
Due Dates: March 30, 2023 (LOI) | July 24, 2023 (Full Proposal) | May 31, 2026 (LOI) | August 14, 2026 (Full Proposal)
Funding Amounts: Up to $450,000 per project for one year; potential annual renewal; indirect costs capped at 10%.
Summary: Supports development of non-surgical, product-oriented therapies for fibrotic complications in IBD, targeting innovative translational approaches.
Key Information: Letter of Intent (LOI) required; full proposals by invitation only; open to both companies and academic groups with commercialization focus.